In vitro anti-lymphoma activity of the first-in-class pan-NOTCH transcription inhibitor CB-103

Affiliations

• ¹ Faculty of Biomedical Sciences, Institute of Oncology Research, USI, Bellinzona, Switzerland.
• ² SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.
• ³ Department of Veterinary Science, University of Turin, Grugliasco, Turin, Italy.
• ⁴ Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
• ⁵ Faculty of Biomedical Sciences, USI, Lugano, Switzerland.
• ⁶ Cellestia Biotech SA, Basel, Switzerland.
• ⁷ Swiss Institute for Experimental Cancer Research, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.